Global dialysis device and concentrates market demand is anticipated to be valued at USD 21,663.5 million in 2023, forecast a CAGR of 4.9% to be valued at USD 34,824.85 million from 2023 to 2033. Growth is attributed to the increasing prevalence of renal disorders. From 2018 to 2022 a CAGR of 3.1% was registered for the dialysis device and concentrates market.
Dialysis is a treatment technique to compensate for poor or lost kidney function. The kidney function is damaged by acute kidney injury or chronic kidney disease. The most common reasons for kidney diseases are urinary infections, diabetes, and genetic kidney diseases.
Dialysis equipment and accessories are used for artificial blood purification in the end stage of renal disease as well as acute kidney injury in dialysis centers or in-home care settings. Dialysis treatment offers a solution to kidney impairment by artificially filtering the blood. The dialysis process regulates water and salts to clean the blood. Patients with kidney failure need dialysis in order to sustain life.
There are two forms of dialysis treatment namely peritoneal dialysis (PD) and haemodialysis (HD). Hemodialysis is a commonly used dialysis technology that treats circulating blood in the dialysis machine. Blood is cleaned as it passes through a dialyzer to diffuse the waste products in dialysis concentrate.
| Attributes | Details |
|---|---|
| Dialysis Device and Concentrates Market CAGR (2023 to 2033) | 4.9% |
| Dialysis Device and Concentrates Market Size (2023) | USD 21,663.5 million |
| Dialysis Device and Concentrates Market Size (2033) | USD 34,824.85 million |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Factors such as the increasing number of patients suffering from hypertension and diabetes and the growing number of end-stage renal disease in patients have been driving the growth of the global dialysis device and concentrate market.
In addition, factors such as technological advancements in products, negligible preference of patients for kidney transplantation, increase in investment for the development of new products, and reimbursement from governments for the treatment of kidney diseases and end-stage renal disease are further expected to propel the growth of the global dialysis and concentrates market.
The global dialysis device and concentrates sector is witnessing steady growth rates with increasing patient populations. The patient population of home hemodialysis (HHD), peritoneal dialysis, and traditional in-center hemodialysis are expected to fuel the growth of the global dialysis device and concentrate the market over the next decade.
For instance –
According to The United States Renal Data System (USRDS)between 2009 and 2019, the percentage of prevalent patients performing home dialysis increased from 8.9% to 13.1%, a relative increase of nearly 50%. Those 13.1% of patients dialyzing at home in 2019 included 1.9% who performed home hemodialysis and 11.2% who performed peritoneal dialysis.
The factors such as product recall, lower awareness of kidney disease treatment modalities, and low adoption of newly developed devices hamper the growth of the global dialysis and concentrates market.
The lack of developed healthcare infrastructure and the low healthcare spending potential of the population are two key factors that result in the slow growth of the dialysis devices and concentrates market. Also, the lack of resources in developing countries is anticipated to be another factor limiting market expansion in the forthcoming period.
As per FMI, the North American market is slated to account for 38.6% of the total market share. The growing incidence of diabetes, obesity, blood pressure, and other lifestyle-related disorders in the United States is expected to increase the prevalence of kidney diseases.
In addition to this, the rising geriatric population in the country is another factor that propels the prevalence of dialysis devices and concentrates. As per the Centers for Disease Control and Prevention, nearly 37 million United States adults are affected by CKD currently. These diseases are more common in people aged 65 years or older (38%), than in people aged 45-64 (12%).
For instance, The American Diabetes Association®(ADA), along with DaVita, announced the launch of an interactive digital experience aimed at helping those living with diabetes prevent and manage kidney disease.
With the growing prevalence of CKD, various governmental and non-governmental authorities and organizations are launching initiatives to educate and support the population dealing with kidney diseases.
This is expected to boost the adoption of dialysis devices, further augmenting the growth of the market in the forthcoming years. For instance, according to the USRDS Annual Data Report (United States Renal Data System, 2020). At the end of 2018, there were 7,433 dialysis facilities in the United States, at which 518,749 patients received dialysis.
In 2022, Europe captured a share of 33.5% in the dialysis devices and concentrates market. Increasing government expenditure in the healthcare sector is expected to boost sales in the forthcoming years. For instance, General government expenditure in the EU on health amounted to € 1 073 billion or 8.0 % of GDP in 2020.
Favorable policies enabling the adoption of technologically advanced medical equipment in the country continue augmenting the growth of the market over the assessment period.
Ongoing research and development in this field are expected to create opportunities for growth for players operating in the market. The rising incidence of such diseases has also encouraged regulatory authorities to accelerate the product development process by initiating funding directives and other aids.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The Asia Pacific is anticipated to exhibit a significant growth rate in the dialysis devices and concentrates market over the forecast period owing to the rising health awareness, growing prevalence of chronic kidney disease, and increasing government initiatives and investments to reduce the burden of chronic kidney disease.
According to the National Kidney Foundation, the number of cases of kidney failure is expected to surge rapidly in developing countries, such as China and India, where the number of elderly people is increasing. This generates lucrative growth prospects within the Asia Pacific dialysis device and concentrates the market during the forecast period.
The new entrants in the dialysis devices and concentrates market are continually indulging in several collaborations and highly investing in research and development activities to provide more convenient solutions to the healthcare industry verticals. Key start-ups that are leading the development of the market are - Jiangxi Sanxin Medtec Co., Ltd, Advin Health Care, soxapharma, Hemant Surgical Industries Ltd, Shanghai Medco Industry Pvt Ltd, Mitra Industries Pvt. Ltd, and Tom Medical Supplies Co., Ltd.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and DaVita Healthcare Partners, Inc account for considerable market size, several regional level players are also operating across key growth regions, particularly in the Asia Pacific.
Key players
The market is estimated to reach USD 34,824.85 million by 2033.
The growth potential of the dialysis device and concentrates market is 4.9% CAGR through 2033.
North America monopolizes the dialysis device and concentrates market.
Surging number of hypertension patients is expected to drive the market forward.
Prevalence of renal disorders is expected to create opportunity for market players.
| Estimated Size, 2024 | USD 11,126.0 million |
|---|---|
| Projected Size, 2034 | USD 17,780.9 million |
| Value-based CAGR (2024 to 2034) | 4.8% |
| Market Size (2024E) | USD 1299.2 million |
|---|---|
| Market Value (2034F) | USD 2198.2 million |
| Value-based CAGR (2024 to 2034) | 5.4% |
Explore Therapeutic Device Insights
View Reports
Dialysis Device And Concentrates Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
